GSK Names New US Pharmaceutical Head

By Emily Forster -

August 14, 2019

GlaxoSmithKline’s (GSK) President of US Pharmaceuticals, Jack Bailey, has decided to step down from his role at the end of 2019. GSK has appointed Maya Martinez-Davis, currently Regional President, Latin America Region at EMD Serono, to succeed him. EMD Serono is the biopharmaceutical business of Merck KGaA.

Martinez-Davis was previously Senior Vice President, Global Oncology at EMD Serono (Merck KGaA). Prior to this, she spent 13 years at Pfizer leading various business units, including oncology and vaccines.

Martinez-Davis will join GSK in mid-September 2019 and will assume responsibility of the US pharmaceuticals business at GSK on January 1, 2020. Bailey will remain as strategic consultant to GSK on the US external environment through 2020.

Source: GlaxoSmithKline